Kezar Life Sciences (Preclinical Assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Kezar Life Sciences (Preclinical Assets) General Information

Description

Preclinical assets located in the United States.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • CA
  • United States
Primary Industry
Buildings and Property
Acquirer
Enodia Therapeutics
Corporate Office
  • CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kezar Life Sciences (Preclinical Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kezar Life Sciences (Preclinical Assets)‘s full profile, request access.

Request a free trial

Kezar Life Sciences (Preclinical Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kezar Life Sciences (Preclinical Assets)‘s full profile, request access.

Request a free trial

Kezar Life Sciences (Preclinical Assets) FAQs

  • Where is Kezar Life Sciences (Preclinical Assets) headquartered?

    Kezar Life Sciences (Preclinical Assets) is headquartered in CA.

  • What industry is Kezar Life Sciences (Preclinical Assets) in?

    Kezar Life Sciences (Preclinical Assets)’s primary industry is Buildings and Property.

  • Is Kezar Life Sciences (Preclinical Assets) a private or public company?

    Kezar Life Sciences (Preclinical Assets) is a Private company.

  • What is the current valuation of Kezar Life Sciences (Preclinical Assets)?

    The current valuation of Kezar Life Sciences (Preclinical Assets) is .

  • What is Kezar Life Sciences (Preclinical Assets)’s current revenue?

    The current revenue for Kezar Life Sciences (Preclinical Assets) is .

  • Who are Kezar Life Sciences (Preclinical Assets)’s investors?

    Kezar Life Sciences has invested in Kezar Life Sciences (Preclinical Assets).

  • When was Kezar Life Sciences (Preclinical Assets) acquired?

    Kezar Life Sciences (Preclinical Assets) was acquired on 06-Mar-2026.

  • Who acquired Kezar Life Sciences (Preclinical Assets)?

    Kezar Life Sciences (Preclinical Assets) was acquired by Enodia Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process